Catherine Wilson
Family · Wakefield, RINPI 1881185270
Payments from drug & device makers
Across 64 payments — averaging $22.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$295
- AbbVie$167
- Amgen$153
- Novo Nordisk$138
- Lilly USA, LLC$109
- Boston Scientific$108
- plus $495 from 11 others
What the payments were for
- Food & beverage$1,464100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 13 | $295 |
| AbbVie | 8 | $167 |
| Amgen | 4 | $153 |
| Novo Nordisk | 7 | $138 |
| Lilly USA, LLC | 6 | $109 |
| Boston Scientific | 1 | $108 |
| Exact Sciences | 3 | $66 |
| AstraZeneca | 4 | $63 |
| Axsome Therapeutics, Inc. | 4 | $61 |
| Astellas Pharma US Inc | 2 | $57 |
| Corcept Therapeutics | 2 | $50 |
| Gilead | 2 | $47 |
| Boehringer Ingelheim | 2 | $45 |
| GSK | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Neos Therapeutics, LP | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,464 in reported general payments places this provider in the 80th percentile of 457 family providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 11 | $3,246 |
| Atorvastatin Calcium | 75 | $1,172 |
| Rosuvastatin Calcium | 33 | $1,160 |
| Ezetimibe | 12 | $767 |
| Escitalopram Oxalate | 18 | $539 |
| Lisinopril | 38 | $501 |
| Metoprolol Succinate | 17 | $469 |
| Losartan Potassium | 14 | $393 |
| Montelukast Sodium | 14 | $375 |
| Trazodone Hcl | 25 | $332 |
| Levothyroxine Sodium | 45 | $298 |
| Amlodipine Besylate | 34 | $295 |
| Carvedilol | 15 | $254 |
| Sertraline Hcl | 23 | $254 |
| Metformin Hcl | 19 | $239 |
Paid to pharmacies, not to this prescriber.
Other family in Wakefield
- Darlene MalesWakefield$3K
- Carol RobinsonWarwick$82K
- Mark ClarkeSmithfield$37K
- Olga FedorenkoCoventry$24K
- Alicia VatterWarwick$15K
- Kaleigh RapozaJohnston$14K
- David RamosRiverside$14K
- Sharon BensonNorth Smithfield$12K
- Michelle Blade MelloWest Warwick$12K
- Shrenik VyasLincoln$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.